Friday, October 23, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Analysts Bullish on Ardelyx NASDAQ ARDX with Positive Price Targets

Elaine Mendonca by Elaine Mendonca
February 23, 2024
in Breaking News
0
0
SHARES
32
VIEWS
Share on FacebookShare on Twitter

Analysts have recently weighed in on Ardelyx (NASDAQ: ARDX) with a mix of opinions, from bullish to bearish.
______________________________________________________________________________________

In the last three months, ratings have included 3 bullish, 4 somewhat bullish, and no indifferent, somewhat bearish, or bearish ratings.
______________________________________________________________________________________

Within the past 30 days, there have been 2 somewhat bullish ratings. The average 12-month price target for Ardelyx is $13.0, with a high estimate of $15.00 and a low estimate of $9.00, reflecting a 23.81% increase from the previous average price target of $10.50.
______________________________________________________________________________________

Recent analyst actions include:
– Christopher Raymond from Piper Sandler upgraded the rating to Overweight with a price target of $15.00.
– Laura Chico from Wedbush maintained an Outperform rating with a price target of $13.00, up from $9.00.
– Yigal Nochomovitz from Citigroup upgraded the rating to Buy with a price target of $14.00.
– Steven Seedhouse from Raymond James upgraded the rating to Strong Buy with a price target of $15.00 and issued another Strong Buy rating with a $12.00 price target.
______________________________________________________________________________________

Overall, analysts are bullish on Ardelyx, with a Buy rating and an average price target of $11.92, suggesting an 84.49% predicted upside based on their 12-month stock forecasts.

ARDX Stock Analysis: Showing Strength Near 52-Week High and Above Moving Average

On February 23, 2024, ARDX stock showed signs of strength as it traded near the top of its 52-week range and above its 200-day simple moving average. This indicates that the stock has been performing well over a longer period of time and may have potential for further growth.

Despite the overall positive trend, the price of ARDX shares held flat on this particular day, with a 0.00% change since the market last closed. The stock opened at $8.16, which was $0.66 lower than its previous close. While this may have initially been seen as a slight dip, it is important to consider the broader context of the stock’s performance.

Investors should take note of the stock’s positioning relative to its 52-week range and moving average, as these factors can provide valuable insights into the stock’s overall health and potential for future growth. Trading near the top of its 52-week range suggests that the stock has been performing well compared to its historical prices, while trading above its 200-day moving average indicates a longer-term positive trend.

It is always important for investors to conduct thorough research and analysis before making any investment decisions. While the flat performance of ARDX stock on February 23 may not have been cause for immediate concern, it is essential to consider the stock’s overall trajectory and potential for growth in the future.

ARDX Stock Shows Impressive Financial Growth in 2024: Revenue, Net Income, and EPS Soar

On February 23, 2024, ARDX stock showed significant improvement in its financial performance compared to the previous year and quarter. According to data from CNN Money, the company reported a total revenue of $52.16 million for the past year, which increased by an impressive 416.57% compared to the previous year. In the third quarter alone, ARDX reported a total revenue of $56.39 million, marking a 152.5% increase from the previous quarter.

Similarly, the company’s net income also showed positive growth trends. ARDX reported a net income of -$67.21 million for the past year, which improved by 57.51% compared to the previous year. In the third quarter, the company reported a net income of $6.63 million, reflecting a substantial increase of 138.72% from the previous quarter.

Moreover, ARDX’s earnings per share (EPS) also experienced significant growth. The company reported an EPS of -$0.42 for the past year, which increased by 72.1% compared to the previous year. In the third quarter, ARDX reported an EPS of $0.03, reflecting a notable increase of 136.56% from the previous quarter.

Overall, ARDX stock demonstrated strong financial performance on February 23, 2024, with substantial increases in total revenue, net income, and earnings per share compared to the previous year and quarter. Investors and analysts may view these positive financial indicators as a sign of the company’s growth and potential for future success.

Tags: ARDX
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Biotechnology Markets and money

The Power of Compounded Returns A Case Study of CRISPR Therapeutics

Alternative Energy Stock Market Today (1)

Kosmos Energy Prepares for Quarterly Earnings Report What to Expect

BioCryst Pharmas Upcoming Earnings Report Analyst Predictions and Investor Expectations

Recommended

BioNTech Stock

BioNTech Investors Face Legal Challenge Following CureVac Acquisition

10 months ago
Eli Lilly Stock

Eli Lilly Faces Pricing Pressure as New Regulations Force Strategic Shift

1 year ago
MMM stock news

WestPark Capital Downgrades Palo Alto Networks to Hold Rating Despite Companys Resolute Stance

3 years ago
Inmune Bio Stock

Inmune Bio Navigates Strategic Shift Amid Market Pressures

1 year ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum DroneShield Eli Lilly FALLBACK Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Netflix Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power Robinhood Rocket Lab USA Salesforce Strategy Take-Two Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics XRP
No Result
View All Result

Highlights

Most Stocks Rose While the Index Fell: Earnings Week Is the Test

Tesla Jumps on a Roadster as Tech Slips Into the Weekend

CoreWeave’s Bonds Flash Red as Strong Earnings Fall Flat

Hot Core CPI Sorts the Stocks: ASML Delivers, J&J Stumbles

Goldman Delivers as Memory Stocks Slide Ahead of CPI

Optics Run Hot as Chip Leaders Pause for Breath

Trending

Bitcoin Stock
Newsletter

Lam, Tesla and Meta Clear the Bar and Still Get Sold

by Stephanie Dugan
October 22, 2026
0

Dear readers, Wednesday's open question got its answer overnight. Lam Research told investors that global spending on...

Danaher Stock

Beat Estimates, Lose Ground: Guidance Now Drives Earnings Season

October 21, 2026
Mastercard Stock

The AI Rally Needs Cheap Money, and Cheap Money Is Scarce

October 20, 2026
Meta Stock

Most Stocks Rose While the Index Fell: Earnings Week Is the Test

October 18, 2026
Tesla Stock

Tesla Jumps on a Roadster as Tech Slips Into the Weekend

October 16, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Lam, Tesla and Meta Clear the Bar and Still Get Sold
  • Beat Estimates, Lose Ground: Guidance Now Drives Earnings Season
  • The AI Rally Needs Cheap Money, and Cheap Money Is Scarce

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com